GB0525661D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0525661D0 GB0525661D0 GBGB0525661.5A GB0525661A GB0525661D0 GB 0525661 D0 GB0525661 D0 GB 0525661D0 GB 0525661 A GB0525661 A GB 0525661A GB 0525661 D0 GB0525661 D0 GB 0525661D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0525661.5A GB0525661D0 (en) | 2005-12-16 | 2005-12-16 | Novel compounds |
| PCT/EP2006/069721 WO2007068739A1 (en) | 2005-12-16 | 2006-12-14 | 4-amino-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, neurological and cardiovascular disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0525661.5A GB0525661D0 (en) | 2005-12-16 | 2005-12-16 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0525661D0 true GB0525661D0 (en) | 2006-01-25 |
Family
ID=35736283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0525661.5A Ceased GB0525661D0 (en) | 2005-12-16 | 2005-12-16 | Novel compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0525661D0 (en) |
| WO (1) | WO2007068739A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR080056A1 (en) | 2010-02-01 | 2012-03-07 | Novartis Ag | CICLOHEXIL-AMIDA DERIVATIVES AS ANTAGONISTS OF CRF RECEIVERS |
| US20120295942A1 (en) | 2010-02-01 | 2012-11-22 | Nicholas James Devereux | Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists |
| CN102753527B (en) | 2010-02-02 | 2014-12-24 | 诺华股份有限公司 | Cyclohexyl amide derivatives as crf receptor antagonists |
| EP2724723A1 (en) * | 2012-10-25 | 2014-04-30 | Universitätsklinikum Hamburg-Eppendorf | Tegaserod for use in the treatment of nerve injuries |
| NZ712369A (en) | 2013-03-20 | 2016-11-25 | Suven Life Sciences Ltd | 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists |
| FR3006686A1 (en) * | 2013-06-05 | 2014-12-12 | Univ Caen | ACETYLCHOLINESTERASE INHIBITOR COMPOUNDS AND PROMOTING EFFECT OF 5HT4 SEROTONINERGIC RECEPTOR AGONISTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| ES2734734T3 (en) * | 2015-02-13 | 2019-12-11 | Suven Life Sciences Ltd | Amide compounds as 5-HT4 receptor agonists |
| CN110950843B (en) * | 2019-11-28 | 2022-12-27 | 广东东阳光药业有限公司 | Substituted benzamide derivatives and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8519707D0 (en) * | 1985-08-06 | 1985-09-11 | Fordonal Sa | Chemical compounds |
| US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| GB9005014D0 (en) * | 1990-03-06 | 1990-05-02 | Janssen Pharmaceutica Nv | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives |
| WO2005092882A1 (en) * | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
-
2005
- 2005-12-16 GB GBGB0525661.5A patent/GB0525661D0/en not_active Ceased
-
2006
- 2006-12-14 WO PCT/EP2006/069721 patent/WO2007068739A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007068739A1 (en) | 2007-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2007004171A0 (en) | Novel compounds | |
| EP1868611A4 (en) | Novel compounds | |
| EP1868612A4 (en) | Novel compounds | |
| GB0525661D0 (en) | Novel compounds | |
| GB0503955D0 (en) | Novel compounds | |
| EP1869026A4 (en) | Novel compounds | |
| GB0500140D0 (en) | Novel compounds | |
| GB0504109D0 (en) | Novel compounds | |
| GB0504098D0 (en) | Novel compounds | |
| GB0503121D0 (en) | Novel compounds | |
| GB0500282D0 (en) | Novel compounds | |
| GB0500284D0 (en) | Novel compounds | |
| GB0500285D0 (en) | Novel compounds | |
| GB0500405D0 (en) | Novel compounds | |
| GB0500406D0 (en) | Novel compounds | |
| GB0500839D0 (en) | Novel polyacetylen compounds | |
| GB0500883D0 (en) | Novel compounds | |
| GB0500884D0 (en) | Novel compounds | |
| GB0500885D0 (en) | Novel compounds | |
| GB0500886D0 (en) | Novel compounds | |
| GB0500887D0 (en) | Novel compounds | |
| GB0503122D0 (en) | Novel compounds | |
| GB0521515D0 (en) | Novel compounds | |
| GB0501962D0 (en) | Novel compounds | |
| GB0504108D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |